| | | | | |
AARD Aardvark Therapeutics, Inc. Common Stock | $5.8700 | -0.85% | $126.71M | $33.49K | |
FXAC FortuneX Acquisition Corporation Ordinary shares | $10.0800 | +0.29% | $126.57M | $9.33K | |
INVZ Innoviz Technologies Ltd. Ordinary shares | $0.33400 | -0.45% | $126.53M | $1.29M | |
SJT San Juan Basin Royalty Trust UBI | $2.8860 | +1.26% | $126.30M | $40.58K | |
SANG Sangoma Technologies Corporation Common Shares | $3.8400 | -1.54% | $126.12M | $13.09K | |
CBUS Cibus, Inc. Class A Common Stock | $1.5350 | -1.60% | $126.10M | $60.11K | |
RDZN Roadzen, Inc. Ordinary Shares | $1.2550 | -9.71% | $126.04M | $417.00K | |
NYXH Nyxoah SA Ordinary Shares | $1.5050 | +1.01% | $126.03M | $63.85K | |
MXCT MaxCyte, Inc. Common Stock | $1.2550 | +1.21% | $125.91M | $357.53K | |
| $19.4750 | -1.04% | $125.78M | $2.33K | |
GGZ The Gabelli Global Small and Mid Cap Value Trust | $16.2800 | +0.56% | $125.64M | $3.81K | |
NMI Nuveen Municipal Income | $10.3950 | -0.53% | $125.61M | $31.15K | |
| $1.1650 | -2.10% | $125.56M | $108.42K | |
BMEA Biomea Fusion, Inc. Common Stock | $1.8750 | +4.17% | $125.39M | $1.40M | |
LIXT Lixte Biotechnology Holdings, Inc. Common Stock | $7.2850 | +1.04% | $125.35M | $610.69K | |
